SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-052027
Filing Date
2015-06-10
Accepted
2015-06-10 18:43:25
Documents
2
Period of Report
2015-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3839
2 POA DOCUMENT poa.txt EX-24.3_589141 3660
  Complete submission text file 0001209191-15-052027.txt   9090
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-532-8833
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Altmeyer Mark (Reporting) CIK: 0001643074 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 15924468